NeoVolta Inc.
Current- Director 2022 to present
Executive record
Alpha ID: alpha:person:susan-snowVersion: public-0As of: 2026-10-03
Connect capital, control, accountability, and evidence.
Susan Snow has served as a director since July 2022. From 2018 to 2021, she was Senior VP of Operations at Redhorse, a consulting firm specializing in U.S. government contracts. Previously, she was a principal at Transitional Finance Partners and began her career at KPMG where she earned her CPA. Since December 2021, she has served as director of Creative Medical Technology Holdings, Inc.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageNo published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAlpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
sec filing · Source published: Nov 13, 2025 · Retrieved: May 15, 2026
sec proxy · Source published: Nov 13, 2025 · Retrieved: Apr 25, 2026
sec filing · Source published: Oct 28, 2025 · Retrieved: May 16, 2026
sec proxy · Source published: Oct 28, 2025 · Retrieved: Apr 28, 2026
public source · Source published: Date unavailable · Retrieved: Date unavailable
public source · Source published: Date unavailable · Retrieved: Date unavailable
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03